[New trends in chemotherapy of systemic lupus erythematosus: treatment with mycophenolate mofetil].
The review covers current issues of pharmacotherapy of systemic lupus erythematosus (SLE) with a focus on a novel immunodepressant mofetil microphenolate (MM) which is not inferior in efficiency to a conventional anti-SLE drug cyclophosphamide which has a worse tolerance.